Company news: AstraZeneca

Share this article:
AstraZeneca chief David Brennan said the company will see nearly a billion dollars shaved off its profits for 2010 and 2011 combined due to healthcare reform legislation in the US, Reuters reported. “My US profit and loss statement for 2010 will take a $300 million hit on healthcare reform and double that next year, so it is a pretty significant impact on our business,” Brennan was quoted as saying at a conference. Gains in sales to previously uninsured Americans are expected to more than make up for that loss in the long term.

When asked if they knew where to find online resources to manage their condition, eight in 10 respondents to a MedTera survey said “Not at all.” Fifty-four percent of the 7,028 respondents also said the same thing when asked if they had the information needed to manage their illness when they left their physicians' offices and when asked if they knew where to find info on side effects, while 53% knew nothing of dietary recommendations for their condition.
 
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.